A food safety control low mass-range proteomics platform for the detection of illicit treatments in veal calves by MALDI-TOF-MS serum profiling

Biotechnology Journal

Volumn 4, Issue 11, 2009, Pages 1596-1609

  Donna, Lorenza Della ^a   Ronci, Maurizio ^b,c   Sacchetta, Paolo ^d,e   Ilio, Carmine Di ^b,d,e   Biolatti, Bartolomeo ^a   Federici, Giorgio ^b,c   Nebbia, Carlo ^a   Urbani, Andrea ^b,c  

^a UNIVERSITY OF TURIN   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d Centro Studi sull'Invecchiamento CeSI   (Italy)

^e UNIVERSITY OF CHIETI   (Italy)

Author keywords

Biomarker; Food safety; Growth promoting agents; Mass spectrometry; Proteomics

Indexed keywords

ANALYTICAL PERFORMANCE; BOVINE SERUM; CHEMICAL AGENT; CONVENTIONAL ANALYTICAL; DISCRIMINATION MODEL; FOOD SAFETY; FOOD SAFETY CONTROL; GROWTH PROMOTING AGENTS; LEAN MEATS; LOW DOSAGE; LOW MASS; MALDI TOF MS; MOLECULAR BIOMARKER; PERFORMANCE ENHANCING; POTENTIAL APPLICATIONS; PROOF OF CONCEPT; PROTEOMICS; UNIVARIATE;

BIOASSAY; BIOCHIPS; BIOMARKERS; BODY FLUIDS; CHEMICAL COMPOUNDS; HEALTH; INDUCTIVELY COUPLED PLASMA; MASS SPECTROMETERS; MASS SPECTROMETRY; MEATS; PROTEINS;

MOLECULAR BIOLOGY;

ALPHA 1 ANTITRYPSIN; ANTITHROMBIN III; APOLIPOPROTEIN C2; APOLIPOPROTEIN C3; BETA 2 MICROGLOBULIN; BLOOD CLOTTING FACTOR 13A; COMPLEMENT COMPONENT C3; COMPLEMENT FACTOR H; CYSTATIN; GLIAL FIBRILLARY ACIDIC PROTEIN; HEMOGLOBIN CHAIN; ILLICIT DRUG; KININOGEN; OROSOMUCOID; PIGMENT EPITHELIUM DERIVED FACTOR; PREALBUMIN; PROTHROMBIN; TRANSFERRIN;

ARTICLE; BREEDING; CALF (BOVINE); CATION EXCHANGE; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; FOOD SAFETY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; SIGNAL TRANSDUCTION; SOLID PHASE EXTRACTION;

ANALYSIS OF VARIANCE; ANIMALS; BIOLOGICAL MARKERS; CATTLE; FOOD INSPECTION; MALE; MEAT; PROTEOMICS; REPRODUCIBILITY OF RESULTS; ROC CURVE; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SUBSTANCE ABUSE DETECTION;

BOS; BOVINAE; PISUM SATIVUM;

EID: 73449101111     PISSN: 18606768     EISSN: 18607314     Source Type: Journal    
DOI: 10.1002/biot.200900085     Document Type: Article

References (33)

1. De Brabander, H. F., Poelmans, S., Schilt, R., Stephany, R. W. et al., Presence and metabolism of the anabolic steroid boldenone in various animal species: A review. Food Addit. Contam. 2004, 21, 515-525.
2. Courtheyn, D., Le Bizec, B., Brambilla, G., De Brabander, H. F. et al., Recent developments in the use and abuse of growth promoters. Anal. Chim. Acta 2002, 473, 71-82.
3. Kuiper, H. A., Noordam, M. Y., van Dooren-Flipsen, M. M., Schilt, R. et al., Illegal use of beta-adrenergic agonists: European Community. J. Anim. Sci. 1998, 76, 195-207.
4. Gardini, G., Del Boccio, P., Colombatto, S., Testore, G. et al., Proteomic investigation in the detection of the illicit treatment of calves with growth-promoting agents. Proteomics 2006, 6, 2813-2822.
5. Ebert, M. P., Korc, M., Malfertheiner, P., Röcken, C., Advances, challenges, and limitations in serum-proteomebased cancer diagnosis. J. Proteome Res. 2006, 5, 19-25.
6. Villanueva, J., Philip, J., Chaparro, C. A., Li, Y. et al., Correcting common errors in identifying cancer-specific serum peptide signatures. J. Proteome Res. 2005, 4, 1060-1072.
7. Matharoo-Ball, B., Miles, A. K., Creaser, C. S., Ball, G. et al., Serum biomarker profiling in cancer studies: A question of standardisation? Vet. Comp. Oncol. 2008, 6, 224-247.
8. Wilkins, M. R., Sanchez, J. C., Gooley, A. A., Appel, R. D. et al., Progress with proteome projects: Why all proteins expressed by a genome should be identified and how to do it. Biotechnol. Genet. Eng. Rev. 1996, 13, 19-50.
9. D'Ambrosio, C., Arena, S., Talamo, F., Ledda, L. et al., Comparative proteomic analysis of mammalian animal tissues and body fluids: Bovine proteome database. J. Chromatogr. B 2005, 815, 157-168.
10. Ardekani, A. M., Liotta, L. A., Petricoin, E. F., III, Clinical potential of proteomics in the diagnosis of ovarian cancer. Expert. Rev. Mol. Diagn. 2002, 2, 312-320.
11. Sanchez, J. C., Appel, R. D., Golaz, O., Pasquali, C. et al., Inside SWISS-2DPAGE database. Electrophoresis 1995, 16, 1131-1151.
12. Sanchez, J. C., Chiappe, D., Converset, V., Hoogland, C. et al., The mouse SWISS-2D PAGE database:A tool for proteomics study of diabetes and obesity. Proteomics 2001, 1, 136-163.
13. Kaji, H., Isobe, T., Protein database of Caenorhabditis elegans. J. Chromatogr. B 2003, 787, 91-99.
14. Wait, R., Miller, I., Eberini, I., Cairoli, F. et al., Strategies for proteomics with incompletely characterized genomes: The proteome of Bos taurus serum. Electrophoresis 2002, 23, 3418-3427.
15. Talamo, F., D'Ambrosio, C., Arena, S., Del Vecchio, P. et al., Proteins from bovine tissues and biological fluids: Defining a reference electrophoresis map for liver, kidney, muscle, plasma and red blood cells. Proteomics 2003, 3, 440-460.
16. Mantini, D., Petrucci, F., Pieragostino, D., Del Boccio, P. et al., LIMPIC:A computational method for the separation of protein MALDI-TOF-MS signals from noise. BMC Bioinformatics 2007, 26, 101.
17. Urbani, A., Gemeinhardt, S., Warne, A., Saraste, M., Properties of the detergent solubilised cytochrome c oxidase (cytochrome cbb(3)) purified from Pseudomonas stutzeri. FEBS Lett. 2001, 508, 29-35.
18. Biroccio, A., Del Boccio, P., Panella, M., Bernardini, S. et al., Differential post-translational modifications of transthyretin in Alzheimer's disease: A study of the cerebral spinal fluid. Proteomics 2006, 6, 2305-2313.
19. Wang, Y., Balgley, B. M., Rudnick, P. A., Lee, C. S., Effects of chromatography conditions on intact protein separations for top-down proteomics. J. Chromatogr. A 2005, 1073, 35-41.
20. Yi, J., Kim, C., Gelfand, C. A., Inhibition of intrinsic proteolytic activities moderates preanalytical variability and instability of human plasma. J. Proteome Res. 2007, 6, 1768-1781.
21. Tammen, H., Schulte, I., Hess, R., Menzel, C. et al., Peptidomic analysis of human blood specimens: Comparison between plasma specimens and serum by differential peptide display. Proteomics 2005, 5, 3414-3422.
22. Baggerly, K. A., Morris, J. S., Edmonson, S. R., Coombes, K. R., Signal in noise: Evaluating reported reproducibility of serum proteomic tests for ovarian cancer. J. Natl. Cancer Inst. 2005, 97, 307-309.
23. Diamandis, E. P., Analysis of serum proteomic patterns for early cancer diagnosis: Drawing attention to potential problems. J. Natl. Cancer Inst. 2004, 96, 353-356.
24. Ransohoff, D. F., Lessons from controversy: Ovarian cancer screening and serum proteomics. J. Natl. Cancer Inst. 2005, 97, 315-319.
25. Guidance for Industry, Bioanalytical Method Validation, U. S. Food and Drug Administration, Center for Drug Evaluation and Research 2001 (CDER).
26. Lopez, M. F., Mikulskis, A., Kuzdzal, S., Bennett, D. A. et al., High-resolution serum proteomic profiling of Alzheimer disease samples reveals disease-specific, carrier-protein-bound mass signatures. Clin. Chem. 2005, 51, 1946-1954.
27. Kochl, S., Fresser, F., Lobentanz, E., Baier, G. et al., Novel interaction of Apolipoprotein (a) with Beta 2 glycoprotein I mediated by the Kringle IV domain. Blood 1997, 90, 1482-1489.
28. Chonn, A., Semple, S. C., Cullis, P. R., Beta 2 glycoprotein I is a major protein associated with very rapidly cleared liposomes in vivo, suggesting a significant role in the immune clearance of "nonself" particles. J. Bio. Chem. 1995, 270, 25845-25849.
29. Brighton, T. A., Hogg, P. J., Dai, Y. P., Murray B. H. et al., Beta 2-glycoprotein I in thrombosis: Evidence for a role as a natural anticoagulant. Br. J. Haematol. 1996, 93, 185-194.
30. Li, Q. G., Blacher, R., Esch, F., Congote, L. F., Isolation from fetal bovine serum of an apolipoprotein-H-like protein which inhibits thymidine incorporation in fetal calf erythroid cells. Biochem. J. 1990, 267, 261-264.
31. Yamada, M., Murakami, K., Wallingford, J. C., Yuki, Y., Identification of low-abundance proteins of bovine colostral and mature milk using two-dimensional electrophoresis followed by microsequencing and mass spectrometry. Electrophoresis 2002, 23, 1153-1160.
32. Hartgens, F., Kuipers, H., Effects of androgenic-anabolic steroids in athletes. Sports Med. 2004, 34, 513-554.
33. Draisci, R., Montesissa, C., Santamaria, B., D'Ambrosio, C. et al., Integrated analytical approach in veal calves administered the anabolic androgenic steroids boldenone and boldione: Urine and plasma kinetic profile and changes in plasma protein expression. Proteomics 2007, 7, 3184-3193.